The WCC Note

Your Weekly Guide to Harmonizing Clinical Trial Imaging

Archive for the ‘Disease Control’ Category

Volume 4, Number 4 – May 6, 2010 FATTY LIVER: The Epidemic Wolf in Sheep’s Clothing, PART 1

Thursday, May 6th, 2010

Nonalcoholic fatty liver disease (NAFLD) has escalated to the number one liver disease in the United States.  No longer just “fatty liver, or fatty liver with focal sparing” noted as almost an afterthought on imaging reports, it has now become an epidemic problem with potential for very real morbidity and mortality.  Afflicting children and adults, its pathogenesis is multifactorial, but its increase prevalence strongly concides with the mounting Western obesity rate.  This issue of  The WCC Note commences a two-part series on hepatic steatosis, beginning with reviews of its prevalence, pathology, and clinical consequences.

How is nonalcoholic fatty liver disease defined?

1.  NAFLD is defined as macrovesicular steatosis in more
than 5% of hepatocytes (1) in the absence of significant
ethol consumption or other specific cause of liver disease.
2.  NAFLD encompasses a spectrum of disease, ranging from:
a.  Simple steatosis
b.  Steatohepatitis (NASH)
c.  Fibrosis and cirrhosis, to
d.  Hepatocellular carcinoma. (2)

How many people have fatty liver?

  1. An estimated 31 million Americans, 31% of men and 16% of women have NAFLD.  It is thought to be the most plausible cause for the elevated serum aminotransferases and/or gamma glutamyl transpeptidase levels recorded in 24% of U.S. adults. (3)
  2. The United States National Institutes of Health estimates that nonalcoholic steatopatitis (NASH) affects 2% to 5% of Americans, with an additional 10% to 20% having fatty liver, i.e. hepatic fat without current inflammation or liver damage. (4)
  3. The true prevalence in children is not known but is reported at 2.5% to 10% and from 8%  to 80% in obese children. (5) NAFLD is reported as a common cause of liver disease in children and adolescents. (1, 6)

Who gets fatty liver?

1.  The most common associations are:
a.  Obesity is the number one cause. Eighty percent of patients with NAFLD are obese, and 80% of  obese
individuals have NAFLD
b.  Type 2 diabetes mellitus
c.  Dyslipidemia (2)
2.  NAFLD affects children, adolescents, (1,6) and adults.  It affects boys more than girls (1) and men and women
equally. (3)
3.   Insulin resistance is reported as almost universal in adults NAFLD and highly prevalent in afflicted children
and adolescents. (1)
4.   Both genetic and environmental factors are thought to be responsible for the major ethnic variations in
prevalence.  (1) Recently, for example, variants in apolipoprotein C3 gene have shown association with
NAFLD. (7)
5.   The current Western diet, high in saturated fats and fructose, is considered highly responsible. (8)

Why does fatty liver disease occur?  What is the pathogenesis?

1. NAFLD is considered to be the liver’s manifestation of a metobolic syndrome called “syndrome X” or “insulin
resistance syndrome.”  The syndrome links NAFLD with obesity, diabetes mellitus type 2, hypertension, and
hyperlipidemia. (1)
2. Evidence points to a two-hit theory.
a.   The first hit:
i.   The  “first hit” involves accumulation of fat in the liver.
ii.  Free fatty acids (FFA) are elevated in the serum, become oversupplied to the liver, and lead to
steatosis. (2)
b.   The second hit:
i    Steatosis makes the liver vulnerable to additional biochemical insults, the “second hit.”  These include
oxidative stree, mitochondrial dysfunction, pro-inflammatory cytokines, adipocytokine imbalance,
dysregulated apoptosis, and stellate cell activation.  The result can lead to inflammation causing NASH
and fibrosis. (5, 9)

What is the pathology of nonalcoholic fatty liver?

1.  Liver steatosis consist of large and small vesicles of fat, predominantly
triglycerides inside hepatocytes. (3)
2.  The histology may differ between children and adult. (10)

Figure at right: Fatty liver in a 44-year -old man.
Axial contrast-enhanced CT scan shows linear high
attenuation along the hepatic surface (arrow), a finding
that represents pseudoenhancement.   The diaphragm has
attenuation of the fatty liver and thus mimics an enhanced
hepatic capsule. (14)

What is the pathology of nonalcoholic steatohepatitis
(NASH) ?1.     Steatosis, multifocal parenchymal inflammation, Mallory hyaline,
hepatocyte death from ballooning degeneration and also apoptosis, and
sinusoidal fibrosis occur. (3)

What effect does fat have on the liver?1.     NAFLD is suspected to be responsible for up to 70% of chronic hepatitis
cases of “unknown” cause.  Studies suggest that cirrhosis may eventually
develop in up to 10% to 30% of those with NAFLD. (3)
2.     NAFLD may contribute to progression of other liver diseases. (3)

What are some recent nutritionally related studies?

1.  Daily frutose ingestion by patients with NAFLD shows association with increase hepatic fibrosis. (11)
2.  In contradistinction, berry consumption has been shown to enhance liver function. (12)

What other diseases are associated with NAFLD?1.  Chronic kidney disease and retinopathy show higher prevalence in type 1 diabetic patients
who have NAFLD. (13)
2.   Hepatic steatosis is an independent marker for increased cardiovascular risk. (10)

Conclusion:  Nonalcoholic fatty liver disease has become the most common chronic liver disease
in Western children, adolescents, and adults.  It can have association with hepatitis, cirrhosis, and
hepatocellular carcinoma.

MRI: Lymphoma, Cardiac & Lead Exposure – Vol. 2, Number 20

Friday, August 1st, 2008

MRI: LYMPHOMA

Imaging of pH Change in Cancer Accomplished in Mice
A change in the acid/base milieu accompanies a variety of pathologic conditions, including cancer, ischemia, and inflammation.  Cancer commonly has an acidic pH and will turn bicarbonate into carbon dioxide.  By harnessing this reaction, lead researchers at Cambridge Research Institute and University of Cambridge accomplished in vivo imaging of the pH alteration in lymphoma.  In a study published in the June 12 issue of Nature, the authors report that they were able to create nontoxic, labeled bicarbonate by utilizing dynamic nuclear polarization (DNP).  The ratio of signal intensities in hyperpolarized bicarbonate into mice with subcutaneous lymphoma revealed that the average interstitial pH in the lymphoma was significantly lower than in the surrounding tissue.  The authors present MRI images of this signal difference.

Conclusion:  In vivo imaging of pH alteration in lymphoma has been achieved in a mouse model using labeled bicarbonate.

MRI: CARDIAC

Late MRI Gadolinium Enhancement Portends Higher Risk of Cardiac Event in Patients with Nonischemic Cardiomyophathy
Patients with nonischemic cardiomyophathy (NICM) underwent gadolinium-enhanced cardiovascular MRI to assess whether the presence and extent of late enhancement correlated with adverse outcomes.  As published in the Journal of the American College of Cardiology, authors from John Hopkins prospectively assessed 65 NICM patients with left ventricular ejection fractions of less than 35%.  The cohort had the MRI examinations prior to receiving implantable cardioverter-defibrillators (ICD).  The results showed that 42% of the group had late gadolinium enhancement.  Of these, 44% had either hospitalization for heart failure, appropriate ICD firing, or cardiac death, compared to 8% of those patients who did not have late enhancement.

Conclusion:  Late gadolinium enhancement correlates with increased risk of cardiac events in patients with nonischemic cardiomyopathy.

MRI: LEAD EXPOSURE

Childhood Lead Exposure Associated with Decreased Brain Volume in Adults
The Centers for Disease Control (CDC) report that approximately 310,000 U.S. children between the ages of one and five have current elevated blood levels greater than the level at which action is recommended – 10 micrograms of lead per deciliter of blood.  Lead causes a variety of toxicities, central nervous system injury being dominant among them.

A recent study led by researchers at Cincinnati Children’s Hospital examined young adults who had experienced elevated childhood lead levels and enrolled in a long-term follow-up study.  The cohort had detailed pre- and postnatal low to moderate lead exposure, with behavioral outcomes monitored over 25 years.  The group underwent whole-brain, high-resolution MRI imaging with assessment of global and regional brain changes using voxel-based morphometry.

The results showed significant reductions in gray-matter volume for several cortical regions in individuals with higher mean childhood lead levels.  As published online at PLoS Medicine, the greatest areas affected included the frontal gray matter, specifically the anterior cingulate cortex.  The lead-associated brain volume loss proved much larger in men than women.  Fine-motor scores correlated positively with the gray-matter volume.

Conclusion:  Childhood lead toxicity is associated with region-specific diminished adult brain volume in areas responsible for mood and decision making, and adversely affects males more than females.